Potential of nanoliposomes for the therapy and/or diagnosis of Alzheimer's disease: recent progress
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potential of nanoliposomes for the therapy and/or diagnosis of Alzheimer's disease: recent progress
Authors
Keywords
-
Journal
Clinical Lipidology
Volume 9, Issue 5, Pages 477-481
Publisher
Future Medicine Ltd
Online
2014-11-27
DOI
10.2217/clp.14.33
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multifunctional nanoliposomes with curcumin–lipid derivative and brain targeting functionality with potential applications for Alzheimer disease
- (2014) Spyridon Mourtas et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A Simplified Method to Attach Antibodies on Liposomes by Biotin-Streptavidin Affinity for Rapid and Economical Screening of Targeted Liposomes
- (2013) Konstantina Papadia et al. Journal of Biomedical Nanotechnology
- Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
- (2013) Anna Salvati et al. Nature Nanotechnology
- Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies
- (2013) E. Markoutsa et al. PHARMACEUTICAL RESEARCH
- Versatile and Efficient Targeting Using a Single Nanoparticulate Platform: Application to Cancer and Alzheimer’s Disease
- (2012) Benjamin Le Droumaguet et al. ACS Nano
- Anti-Aβ-MAb and dually decorated nanoliposomes: Effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells
- (2012) Eleni Markoutsa et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Curcumin-conjugated nanoliposomes with high affinity for Aβ deposits: Possible applications to Alzheimer disease
- (2012) Adina N. Lazar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Nanotechnological advances for the delivery of CNS therapeutics
- (2011) Ho Lun Wong et al. ADVANCED DRUG DELIVERY REVIEWS
- The binding affinity of anti-Aβ1-42 MAb-decorated nanoliposomes to Aβ1-42 peptides in vitro and to amyloid deposits in post-mortem tissue
- (2011) Mara Canovi et al. BIOMATERIALS
- Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells
- (2011) Erika Bereczki et al. Nanomedicine-Nanotechnology Biology and Medicine
- Magnetoliposomes with high USPIO entrapping efficiency, stability and magnetic properties
- (2011) Athanasios Skouras et al. Nanomedicine-Nanotechnology Biology and Medicine
- Effect of curcumin-associated and lipid ligand-functionalized nanoliposomes on aggregation of the Alzheimer's Aβ peptide
- (2011) Mark Taylor et al. Nanomedicine-Nanotechnology Biology and Medicine
- Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model
- (2011) Francesca Re et al. Nanomedicine-Nanotechnology Biology and Medicine
- Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide
- (2010) Marco Gobbi et al. BIOMATERIALS
- Curcumin-decorated nanoliposomes with very high affinity for amyloid-β1-42 peptide
- (2010) Spyridon Mourtas et al. BIOMATERIALS
- Beta Amyloid Aggregation Inhibitors: Small Molecules as Candidate Drugs for Therapy of Alzheimers Disease
- (2010) F. Re et al. CURRENT MEDICINAL CHEMISTRY
- Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line
- (2010) Eleni Markoutsa et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started